# ClinicalTrials.gov record NCT00797823

> PeptideScanner retained ClinicalTrials.gov record NCT00797823 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-10-07, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct00797823-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2011-10-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00797823-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00797823-glucagon-v1.json
- Content SHA-256: `8e1d5ab8a1f2826c6d2d8da754f5bf647ba094943446bf49b79e4aabc4e96fae`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00797823 ([`ctg-observation-nct00797823-2011-10-07-57a635bb346b`](#source-ctg-observation-nct00797823-2011-10-07-57a635bb346b))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00797823 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-10-07, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct00797823-2011-10-07-57a635bb346b`](#source-ctg-observation-nct00797823-2011-10-07-57a635bb346b))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00797823 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-10-07, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct00797823-2011-10-07-57a635bb346b`](#source-ctg-observation-nct00797823-2011-10-07-57a635bb346b))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00797823-2011-10-07-57a635bb346b`](#source-ctg-observation-nct00797823-2011-10-07-57a635bb346b))

## Sources

<a id="source-ctg-observation-nct00797823-2011-10-07-57a635bb346b"></a>
- **ClinicalTrials.gov record NCT00797823 · retained source version 2011-10-07:57a635bb346b71d52fa65000883c02119f03b7cd0ecddb31dc88fef4b5c228e2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00797823) (`ctg-observation-nct00797823-2011-10-07-57a635bb346b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00797823." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00797823-glucagon-v1.json SHA-256: 8e1d5ab8a1f2826c6d2d8da754f5bf647ba094943446bf49b79e4aabc4e96fae.